We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.67% |
| 2 | Healthcare | 15.33% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Newell Brands
NWL
$2.47B
| $1.16M | ﹤0.01% |
75,669
-1,386
| -2% | -$25.5K |
|
|
EBIX
927
DELISTED
Ebix Inc
EBIX
| $1.16M | ﹤0.01% |
23,500
+9,050
| +63% | +$477K |
|
|
HIBB
928
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.16M | ﹤0.01% |
50,800
+33,200
| +189% | +$585K |
|
929
Manitowoc
MTW
$745M
| $1.15M | ﹤0.01% |
+70,000
| New | +$1.17M |
|
930
Red Robin
RRGB
$139M
| $1.15M | ﹤0.01% |
39,800
+22,600
| +131% | +$697K |
|
931
Invesco S&P 500 BuyWrite ETF
PBP
$382M
| $1.14M | ﹤0.01% |
54,410
+1,440
| +3% | +$29.6K |
|
932
Healthpeak Properties
DOC
$14B
| $1.14M | ﹤0.01% |
36,487
-1,326
| -4% | -$40.4K |
|
933
ON Semiconductor
ON
$28B
| $1.13M | ﹤0.01% |
55,000
-9,688
| -15% | -$200K |
|
|
ALDR
934
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.13M | ﹤0.01% |
82,700
+18,700
| +29% | +$242K |
|
935
Fortive
FTV
$16.8B
| $1.12M | ﹤0.01% |
21,227
-300,520
| -93% | -$14.6M |
|
|
SNCR
936
DELISTED
Synchronoss Technologies
SNCR
| $1.12M | ﹤0.01% |
+20,467
| New | +$1.33M |
|
|
LOGM
937
DELISTED
LogMein, Inc.
LOGM
| $1.11M | ﹤0.01% |
+13,900
| New | +$1.19M |
|
938
iShares Core US REIT ETF
USRT
$4.4B
| $1.11M | ﹤0.01% |
21,450
-850
| -4% | -$42.1K |
|
|
CVSA
939
Covista Inc
CVSA
$4.35B
| $1.11M | ﹤0.01% |
23,889
+5,221
| +28% | +$251K |
|
940
Cimpress
CMPR
$2.02B
| $1.1M | ﹤0.01% |
13,735
| – | – |
|
|
NPTN
941
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.09M | ﹤0.01% |
173,200
-14,000
| -7% | -$98.1K |
|
|
SKX
942
DELISTED
Skechers
SKX
| $1.09M | ﹤0.01% |
32,300
-1,500
| -4% | -$44.8K |
|
943
Hancock Whitney
HWC
$6.06B
| $1.07M | ﹤0.01% |
+26,600
| New | +$1.09M |
|
944
Bausch Health
BHC
$2.15B
| $1.07M | ﹤0.01% |
43,457
-559
| -1% | -$13.3K |
|
945
Vermilion Energy
VET
$1.96B
| $1.07M | ﹤0.01% |
43,334
+6,134
| +16% | +$150K |
|
946
Global Net Lease
GNL
$2.09B
| $1.07M | ﹤0.01% |
56,400
-191,900
| -77% | -$3.66M |
|
947
Shinhan Financial Group
SHG
$38.9B
| $1.03M | ﹤0.01% |
27,714
| – | – |
|
948
Criteo S.A.
CRTO
$833M
| $1.02M | ﹤0.01% |
51,102
| – | – |
|
949
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $1.02M | ﹤0.01% |
26,875
+7,600
| +39% | +$281K |
|
950
Entravision Communication
EVC
$746M
| $1.01M | ﹤0.01% |
313,101
-161,799
| -34% | -$599K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.